3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Non-Metastatic Prostate Cancer: new trials by email Literature Review of Non-Metastatic Prostate Cancer trials Research Report on Non-Metastatic Prostate Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Casodex vs Placebo in Non-Metastatic Early Prostate Cancer Bicalutamide, Placebo - Non-Metastatic Prostate Cancer | Phase 3 | Completed | AstraZeneca | 1218 | 1995-10-01 | 2009-05-27 |
| (Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer Bicalutamide, Placebo - Non-Metastatic Prostate Cancer | Phase 3 | Completed | AstraZeneca | 3588 | 1995-09-01 | 2010-12-10 |
| Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer Bicalutamide, Placebo - Non-metastatic Prostate Cancer | Phase 3 | Completed | AstraZeneca | 3618 | 1995-08-01 | 2012-06-06 |
Genital Diseases (3) · Genital Diseases, Male (3) · Genital Neoplasms, Male (3) · Male Urogenital Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Prostatic Diseases (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3)
bicalutamide (3)
AstraZeneca (3)
Australia (1) · Austria (1) · Belgium (1) · Canada (1) · Czechia (1) · Denmark (1) · Finland (1) · Germany (1) · Hungary (1) · Ireland (1) · Israel (1) · Italy (1) · Mexico (1) · Netherlands (1) · Norway (1)
David G. McLeod (1) · Manfred P Wirth, Professor (1) · Peter Iversen, MD (1) · William See (1)